CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,180 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,788 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 985 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 1,033 shares (to pay taxes)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 62,500 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 53,750 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 150,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 50,000 shares (grant or award)
- 8-K Event Other events
- 4 Shares withheld for taxes Chief Scientific Officer gave up 876 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 834 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 999 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,310 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,576 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 12,657 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 16 of 24 · 464 filings